R82.0 Chyluria

Name of the Condition

• Chyluria

Summary

Chyluria is a condition characterized by the presence of chyle (a milky fluid containing fat) in the urine, resulting in a cloudy or milky appearance. This occurs due to abnormal communication between the lymphatic system and the urinary tract, typically from lymphatic leakage into the renal collecting system. The condition is often detected incidentally during urinalysis or when patients report unusual urine color.

Causes

Chyluria is most commonly caused by filarial infections, particularly Wuchereria bancrofti, which can damage lymphatic vessels in the retroperitoneum or renal pelvis. Other causes include trauma, tumors, or congenital abnormalities affecting the lymphatic-urinary tract connection. In some cases, it may be associated with conditions like lymphatic malformations or post-surgical complications.

Risk Factors

• Residence in or travel to regions endemic for filarial infections (e.g., tropical and subtropical areas)
• History of lymphatic system disorders or surgeries
• Underlying malignancies or inflammatory conditions affecting the retroperitoneum
• Congenital lymphatic abnormalities

Symptoms

• Milky, cloudy, or oily-appearing urine
• Possible associated urinary symptoms (e.g., dysuria, frequency) if infection or inflammation is present
• Fatigue or weight loss in chronic cases due to loss of lymphatic fluid and nutrients

Diagnosis

Diagnosis involves urinalysis to confirm the presence of chyle (e.g., Sudan III staining for fat globules) and may include imaging studies such as lymphangiography, ultrasound, or CT scans to identify the source of lymphatic leakage. Additional tests may assess for underlying causes, such as filarial serology or biopsy if malignancy is suspected.

Treatment Options

Treatment focuses on addressing the underlying cause. For filarial chyluria, antiparasitic therapy and supportive care may be used. In other cases, interventions like lymphatic ligation, sclerotherapy, or dietary modifications (e.g., low-fat diets) may be employed. Severe or refractory cases might require surgical repair of the lymphatic-urinary tract fistula.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and response to treatment. Filarial chyluria often improves with appropriate therapy, while structural or congenital causes may require ongoing management. Follow-up typically includes monitoring urine appearance, repeat imaging if needed, and addressing any nutritional deficiencies from chronic chyle loss.

Complications

• Nutritional deficiencies (e.g., protein, fat-soluble vitamins) due to chronic chyle loss
• Recurrent urinary tract infections
• Kidney damage from prolonged lymphatic obstruction or infection
• Psychological distress from persistent urinary changes

Lifestyle & Prevention

• In endemic regions, preventive measures against filarial infections (e.g., mosquito control, prophylactic treatment) may reduce risk.
• Maintaining good hygiene and promptly treating lymphatic system injuries or infections can help prevent secondary chyluria.
• Dietary adjustments (e.g., low-fat diets) may alleviate symptoms in some cases.

When to Seek Professional Help

Seek medical attention if you notice persistent milky or cloudy urine, especially with associated symptoms like pain, fever, or unexplained weight loss. Early evaluation is important to identify and treat underlying causes, particularly infectious or structural issues.

Tips for Medical Coders

When coding for chyluria (R82.0), ensure documentation supports the diagnosis, including urinalysis findings (e.g., chyle presence) and any identified underlying causes. Note that R82.0 is a symptom/sign code and should be used appropriately with a primary diagnosis if available. Verify that the code aligns with the clinical scenario and avoid using it for unrelated urinary abnormalities.